871 related articles for article (PubMed ID: 32956767)
1. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
4. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
[TBL] [Abstract][Full Text] [Related]
5. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
Zins K; Abraham D
Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor-associated macrophages to synergize tumor immunotherapy.
Xiang X; Wang J; Lu D; Xu X
Signal Transduct Target Ther; 2021 Feb; 6(1):75. PubMed ID: 33619259
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
8. Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.
Giannone G; Ghisoni E; Genta S; Scotto G; Tuninetti V; Turinetto M; Valabrega G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575899
[TBL] [Abstract][Full Text] [Related]
9. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy.
Binnewies M; Pollack JL; Rudolph J; Dash S; Abushawish M; Lee T; Jahchan NS; Canaday P; Lu E; Norng M; Mankikar S; Liu VM; Du X; Chen A; Mehta R; Palmer R; Juric V; Liang L; Baker KP; Reyno L; Krummel MF; Streuli M; Sriram V
Cell Rep; 2021 Oct; 37(3):109844. PubMed ID: 34686340
[TBL] [Abstract][Full Text] [Related]
10. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
Front Immunol; 2021; 12():799428. PubMed ID: 34992609
[TBL] [Abstract][Full Text] [Related]
12. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy.
Medvedeva GF; Kuzmina DO; Nuzhina J; Shtil AA; Dukhinova MS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800829
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
Li S; Sheng J; Zhang D; Qin H
Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
[TBL] [Abstract][Full Text] [Related]
15. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
16. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
Chen D; Zhang X; Li Z; Zhu B
Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
[TBL] [Abstract][Full Text] [Related]
17. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
18. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
20. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]